These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 26209072)
1. Development and validation of X-ray diffraction method for quantitative determination of crystallinity in warfarin sodium products. Siddiqui A; Rahman Z; Korang-Yeboah M; Khan MA Int J Pharm; 2015 Sep; 493(1-2):1-6. PubMed ID: 26209072 [TBL] [Abstract][Full Text] [Related]
2. Application of NIR chemometric methods for quantification of the crystalline fraction of warfarin sodium in drug product. Korang-Yeboah M; Akhtar S; Siddiqui A; Rahman Z; Khan MA Drug Dev Ind Pharm; 2016; 42(4):584-94. PubMed ID: 26161939 [TBL] [Abstract][Full Text] [Related]
3. A headspace-gas chromatography method for isopropanol determination in warfarin sodium products as a measure of drug crystallinity. Rahman Z; Akhtar S; Siddiqui A; Ciavarella AB; Nguyenpho A; Faustino PJ; Khan MA Acta Pharm; 2018 Mar; 68(1):31-46. PubMed ID: 29453909 [TBL] [Abstract][Full Text] [Related]
4. Understanding effect of formulation and manufacturing variables on the critical quality attributes of warfarin sodium product. Rahman Z; Korang-Yeboah M; Siddiqui A; Mohammad A; Khan MA Int J Pharm; 2015 Nov; 495(1):19-30. PubMed ID: 26319638 [TBL] [Abstract][Full Text] [Related]
5. Chemometric methods for the quantification of crystalline tacrolimus in solid dispersion by powder X-ray diffractrometry. Siddiqui A; Rahman Z; Bykadi S; Khan MA J Pharm Sci; 2014 Sep; 103(9):2819-2828. PubMed ID: 24585357 [TBL] [Abstract][Full Text] [Related]
6. Chemometric Model Development and Comparison of Raman and (13)C Solid-State Nuclear Magnetic Resonance-Chemometric Methods for Quantification of Crystalline/Amorphous Warfarin Sodium Fraction in the Formulations. Rahman Z; Mohammad A; Akhtar S; Siddiqui A; Korang-Yeboah M; Khan MA J Pharm Sci; 2015 Aug; 104(8):2550-8. PubMed ID: 26096869 [TBL] [Abstract][Full Text] [Related]
7. Quantitative determination of crystallinity of alpha-lactose monohydrate by Near Infrared Spectroscopy (NIRS). Gombás A; Antal I; Szabó-Révész P; Marton S; Erõs I Int J Pharm; 2003 Apr; 256(1-2):25-32. PubMed ID: 12695008 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of In-Use Stability of Anticoagulant Drug Products: Warfarin Sodium. Nguyenpho A; Ciavarella AB; Siddiqui A; Rahman Z; Akhtar S; Hunt R; Korang-Yeboah M; Khan MA J Pharm Sci; 2015 Dec; 104(12):4232-4240. PubMed ID: 26501849 [TBL] [Abstract][Full Text] [Related]
9. Determination of tacrolimus crystalline fraction in the commercial immediate release amorphous solid dispersion products by a standardized X-ray powder diffraction method with chemometrics. Rahman Z; Siddiqui A; Bykadi S; Khan MA Int J Pharm; 2014 Nov; 475(1-2):462-70. PubMed ID: 25173870 [TBL] [Abstract][Full Text] [Related]
10. Quantification of gabapentin polymorphs in gabapentin/excipient mixtures using solid state Tinmanee R; Larsen SC; Morris KR; Kirsch LE J Pharm Biomed Anal; 2017 Nov; 146():29-36. PubMed ID: 28843174 [TBL] [Abstract][Full Text] [Related]
11. Quantitative determination of micronization-induced changes in the solid state of lactose. Della Bella A; Müller M; Soldati L; Elviri L; Bettini R Int J Pharm; 2016 May; 505(1-2):383-93. PubMed ID: 27090154 [TBL] [Abstract][Full Text] [Related]
12. Determination of binary polymorphic mixtures of fluconazole using near infrared spectroscopy and X-ray powder diffraction: a comparative study based on the pre-validation stage results. Ziémons E; Bourichi H; Mantanus J; Rozet E; Lebrun P; Essassi E; Cherrah Y; Bouklouze A; Hubert P J Pharm Biomed Anal; 2011 Jul; 55(5):1208-12. PubMed ID: 21466938 [TBL] [Abstract][Full Text] [Related]
13. Identification of Polymorphic Forms of Active Pharmaceutical Ingredient in Low-Concentration Dry Powder Formulations by Synchrotron X-Ray Powder Diffraction. Egusa K; Okazaki F; Schiewe J; Werthmann U; Wolkenhauer M Drugs R D; 2017 Sep; 17(3):413-418. PubMed ID: 28905245 [TBL] [Abstract][Full Text] [Related]
14. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell. Timmermann IL; Steckel H; Trunk M Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465 [TBL] [Abstract][Full Text] [Related]
15. Powder X-ray diffraction method for the quantification of cocrystals in the crystallization mixture. Padrela L; de Azevedo EG; Velaga SP Drug Dev Ind Pharm; 2012 Aug; 38(8):923-9. PubMed ID: 22092083 [TBL] [Abstract][Full Text] [Related]